These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Viral Origin, Clinical Course, and Renal Outcomes in Patients With BK Virus Infection After Living-Donor Renal Transplantation. Schwarz A; Linnenweber-Held S; Heim A; Framke T; Haller H; Schmitt C Transplantation; 2016 Apr; 100(4):844-53. PubMed ID: 26720302 [TBL] [Abstract][Full Text] [Related]
5. CMV and BKPyV Infections in Renal Transplant Recipients Receiving an mTOR Inhibitor-Based Regimen Versus a CNI-Based Regimen: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials. Mallat SG; Tanios BY; Itani HS; Lotfi T; McMullan C; Gabardi S; Akl EA; Azzi JR Clin J Am Soc Nephrol; 2017 Aug; 12(8):1321-1336. PubMed ID: 28576905 [TBL] [Abstract][Full Text] [Related]
6. Screening for BK Viremia/Viruria and the Impact of Management of BK Virus Nephropathy in Renal Transplant Recipients. Zakaria ZE; Elokely AM; Ghorab AA; Bakr AI; Halim MA; Gheith OA; Nagib AM; Makkeyah Y; Balaha MA; Magdy MM; Al-Otaibi T Exp Clin Transplant; 2019 Jan; 17(Suppl 1):83-91. PubMed ID: 30777529 [TBL] [Abstract][Full Text] [Related]
7. Correlation of BK Virus Neutralizing Serostatus With the Incidence of BK Viremia in Kidney Transplant Recipients. Abend JR; Changala M; Sathe A; Casey F; Kistler A; Chandran S; Howard A; Wojciechowski D Transplantation; 2017 Jun; 101(6):1495-1505. PubMed ID: 27854236 [TBL] [Abstract][Full Text] [Related]
8. BK Virus in Renal Transplant Patients Using Alemtuzumab for Induction Immunosuppression. Korneffel K; Gehring B; Rospert D; Rees M; Ortiz J Exp Clin Transplant; 2020 Oct; 18(5):557-563. PubMed ID: 31324134 [TBL] [Abstract][Full Text] [Related]
9. Long-Term Follow-Up of Active Treatment Versus Minimization of Immunosuppressive Agents in Patients With BK Virus-Associated Nephropathy After Kidney Transplant. Halim MA; Al-Otaibi T; Gheith O; Mosaad A; Zakaria Z; Said T; Nair P; Nampoory NM Exp Clin Transplant; 2016 Feb; 14(1):58-65. PubMed ID: 26862825 [TBL] [Abstract][Full Text] [Related]
10. Elimination of BK viremia in renal transplant recipients by optimization of immunosuppressive medications without precipitating acute rejection. Jha A; Ahmed W; Pakkyara A; Shaheen F; Al Salmi I Saudi J Kidney Dis Transpl; 2018; 29(5):1073-1081. PubMed ID: 30381503 [TBL] [Abstract][Full Text] [Related]
11. Management of BK virus nephropathy in kidney transplant recipients at the Royal Hospital - Clinical Audit - Oman. Al-Raisi F; Mohsin N; Kamble P Exp Clin Transplant; 2015 Apr; 13 Suppl 1():156-8. PubMed ID: 25894146 [TBL] [Abstract][Full Text] [Related]
12. 25-hydroxyvitamin D deficiency and opportunistic viral infections after kidney transplant. Rech MA; Fleming JN; Moore CL Exp Clin Transplant; 2014 Apr; 12(2):95-100. PubMed ID: 24702139 [TBL] [Abstract][Full Text] [Related]
13. Differential Diagnosis of Interstitial Allograft Rejection and BKV Nephropathy by T-cell Receptor Sequencing. Stervbo U; Nienen M; Hecht J; Viebahn R; Amann K; Westhoff TH; Babel N Transplantation; 2020 Apr; 104(4):e107-e108. PubMed ID: 32224816 [No Abstract] [Full Text] [Related]
14. BK Virus in Kidney Transplant: Current Concepts, Recent Advances, and Future Directions. Sharma R; Tzetzo S; Patel S; Zachariah M; Sharma S; Melendy T Exp Clin Transplant; 2016 Aug; 14(4):377-84. PubMed ID: 27267780 [TBL] [Abstract][Full Text] [Related]
15. Risk factors in the progression of BK virus-associated nephropathy in renal transplant recipients. Lee HM; Jang IA; Lee D; Kang EJ; Choi BS; Park CW; Choi YJ; Yang CW; Kim YS; Chung BH Korean J Intern Med; 2015 Nov; 30(6):865-72. PubMed ID: 26552462 [TBL] [Abstract][Full Text] [Related]
16. Co-existence of BKV nephropathy and disseminated tuberculosis in transplant recipient. Al-Warthan S; Al-Hwiesh A Saudi J Kidney Dis Transpl; 2014 Sep; 25(5):1046-50. PubMed ID: 25193905 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and Risk Factors of BK Viremia and Clinical Impact of BK Virus Surveillance on Outcomes in Kidney Transplant Recipients: A Single-Center Cross-Sectional Study. Ji J; Feng S; Jiang Y; Wang W; Zhang X Exp Clin Transplant; 2019 Dec; 17(6):727-731. PubMed ID: 30995893 [TBL] [Abstract][Full Text] [Related]
18. Simultaneous monitoring of CMV and BKV by quantitative PCR in renal transplant recipients. Wu CZ; Chen XQ; Wang ZY; Pan XD; Bai YH; Yang YR; Zheng SL; Xia P J Virol Methods; 2014 Dec; 210():40-4. PubMed ID: 25261811 [TBL] [Abstract][Full Text] [Related]
19. BK Virus nephropathy in living donor renal allograft recipients: An observational study from a large transplant center in India. Gupta P; Gupta A; Bhalla AK; Malik M; Gupta A; Bhargava V; Rana DS Saudi J Kidney Dis Transpl; 2018; 29(6):1366-1370. PubMed ID: 30588968 [TBL] [Abstract][Full Text] [Related]
20. Temporal serum creatinine increase and exacerbation of tubulointerstitial inflammation during the first two months in resolving polyomavirus BK nephropathy. Masutani K; Tsuchimoto A; Matsukuma Y; Kurihara K; Nishiki T; Kitada H; Tanaka M; Kitazono T; Tsuruya K Nephrology (Carlton); 2015 Jul; 20 Suppl 2():45-50. PubMed ID: 26031586 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]